Hemoglobin level in dialysis patients: Revisiting the normal hematocrit study

The relationship between hemoglobin level with PTH level and dialysis adequacy in chronic hemodialysis patients

Background: The role of high levels of parathyroid hormone in the development of anemia either directly or by mediating mechanisms is unclear, and there is a controversy about the pathophysiological role of parathyroid hormone (PTH) in the development and intensification of anemia associated with renal disease. The aim of this study was to investigate the relationship between anemia and parathy...

Hemoglobin variability in dialysis patients.

Anemia management in peritoneal dialysis patients: can an iron supplement maintain a normal transferrin saturation and hemoglobin level?

The primary cause of anemia in dialysis patients is inadequate production of erythropoietin (EPO) by the dysfunctional kidneys. The EPO circulates in plasma and acts on erythroid progenitor cells in the bone marrow to produce red blood cells (RBCs). At the same time, chronic inflammatory diseases reduce the release of iron from storage sites, resulting in low transferrin saturation (Fe+ sat%). ...

Hematocrit level in patients with stroke or ischemic heart disease,Khorasan, 2002-2003

Introduction: Elevated hematocrit is associated with high blood viscosity and could lead to vascular thrombosis. The purpose of this study is to compare hematocit of ischemic stroke and myocardial infarction patients. Methods: All of the patients with ischemic stroke and myocardial infarction (MI) admitted in Vali-e-asr Hospital, Khorasan during 2002-2003 enrolled in this descriptive analytic...

Intercurrent events and comorbid conditions influence hemoglobin level variability in dialysis patients.

BACKGROUND To help identify factors contributing to intra-patient Hb variability, pooled records were analyzed from 5,592 patients undergoing hemodialysis (HD) in European, multicenter, open-label, single-arm Phase 3b trials. PATIENTS AND METHODS Patients previously treated with recombinant human erythropoietin (rHuEPO) were switched to darbepoietin-alpha administered once a week (QW) or once...